ARHGEF39 has been indicated to play a potential carcinogenic role in the development of human hepatocellular carcinoma, gastric cancer and non-small cell lung cancer (Wang et al., 2012, 2018; Zhou et al., 2018). Here, ARHGEF39 is linked to gastric cancer.